Title: Chronic myelogenous leukemia: mechanisms underlying disease progression
Authors: Shet, A S ×
Jahagirdar, B N
Verfaillie, Catherine #
Issue Date: Aug-2002
Series Title: Leukemia vol:16 issue:8 pages:1402-11
Abstract: Chronic myelogenous leukemia (CML), characterized by the BCR-ABL gene rearrangement, has been extensively studied. Significant progress has been made in the area of BCR-ABL-mediated intracellular signaling, which has led to a better understanding of BCR-ABL-mediated clinical features in chronic phase CML. Disease progression and blast crisis CML is associated with characteristic non-random cytogenetic and molecular events. These can be viewed as increased oncogenic activity or loss of tumor suppressor activity. However, what causes transformation and disease progression to blast crisis is only poorly understood. This is in part due to the lack of a good in vivo model of chronic phase CML even though animal models developed over the last few years have started to provide insights into blast crisis development. Thus, additional in vitro and in vivo studies will be needed to provide a complete understanding of the contribution of BCR-ABL and other genes to disease progression and to improve therapeutic approaches for blast crisis CML.
ISSN: 0887-6924
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Interdepartemental Stem Cell Institute (-)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Shet AS, Leukemia. 2002.pdf Published 250KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science